Translational Development AcTDAC

13F holders, Q2 2026 (June 30)
35holders −13
6new positions
19sold out
$10.70avg. 13F price*

At the end of Q2 2026, 35 institutions reported holding Translational Development Ac (TDAC) in their 13F filings, down 13 from Q1 2026. 6 opened new positions and 19 sold out. The largest holders were Linden Advisors LP ($12.3M), Kryger Capital LLC ($12.2M) and Magnetar Financial LLC ($10.7M).

Company
Translational Development Ac
CUSIP
G9008W105
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2025: 30Q1 2025Q2 2025: 38Q2 2025Q3 2025: 41Q3 2025Q4 2025: 44Q4 2025Q1 2026: 48Q1 2026Q2 2026: 35Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions6$21.6M
Exits19$46.5M

All 13F filers, Q1 2026 → Q2 2026: 4,207,645 shares bought and 6,035,292 shares sold, net −1,827,647 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 35 holders

Linden Advisors LP 0.55% Add +91.7% 1,150,000 $12.3M
Kryger Capital LLC 0.70% New 1,141,050 $12.2M
Magnetar Financial LLC 0.11% Reduce -23.1% 1,000,000 $10.7M
AQR Arbitrage LLC 0.18% Reduce -11.0% 974,300 $10.4M
Wolverine Asset Management LLC 0.52% Reduce -24.5% 944,878 $10.1M
Meteora Capital, LLC 0.83% Add +258.6% 919,000 $9.8M
Highbridge Capital Management LLC 0.61% Add +2130.5% 861,837 $9.2M
LMR Partners LLP 0.08% No change 800,000 $8.6M
TENOR CAPITAL MANAGEMENT Co., L.P. 0.46% No change 635,399 $6.8M
Alberta Investment Management Corp 0.04% No change 600,000 $6.4M
Polar Asset Management Partners Inc. 0.14% Reduce -10.1% 539,510 $5.8M
Rivernorth Capital Management, LLC 0.26% No change 500,000 $5.4M
Picton Mahoney Asset Management 0.05% No change 475,002 $5.1M
Glazer Capital, LLC 0.10% Reduce -2.4% 380,933 $4.1M
Calamos Advisors LLC 0.02% New 371,532 $4.0M
Sona Asset Management (us) LLC 0.19% No change 369,960 $4.0M
Goldman Sachs Group Inc. 0.00% Reduce -11.0% 342,787 $3.7M
Mizuho Securities USA LLC 0.06% Reduce -18.2% 328,012 $3.5M
Berkley W R Corp. 0.17% Add +18.2% 322,658 $3.4M
Radcliffe Capital Management, L.P. 0.30% Reduce -46.2% 271,940 $2.9M
Centiva Capital, LP 0.09% Add +66.7% 250,000 $2.7M
Boothbay Fund Management, LLC 0.05% New 232,034 $2.5M
Shaolin Capital Management LLC 0.24% Reduce -8.0% 200,760 $2.1M
Cantor Fitzgerald, L. P. 0.03% New 153,850 $1.6M
Periscope Capital Inc. 0.22% Reduce -58.3% 125,000 $1.3M
Westchester Capital Management, LLC 0.07% Reduce -50.0% 124,328 $1.3M
Moore Capital Management, LP 0.03% No change 100,000 $1.1M
Schonfeld Strategic Advisors LLC 0.01% Reduce -34.3% 98,630 $1.1M
Brevan Howard Capital Management LP 0.01% New 60,533 $648K
Yakira Capital Management, Inc. 0.19% New 60,000 $641K
Verition Fund Management LLC 0.00% Reduce -72.4% 46,687 $499K
Geode Capital Management, LLC 0.00% No change 16,554 $177K
Clear Street Group Inc. 0.00% Add +152.1% 4,963 $53K
BNP Paribas Financial Markets 0.00% Reduce -11.0% 3,513 $38K
Morgan Stanley 0.00% Reduce -20.5% 62 $663

"% of holder's portfolio" is TDAC's weight in each manager's 13F, not the share of Translational Development Ac the manager owns.